Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab

Published:2015-10 Issue:10 Volume:34 Page:1283-1291
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Ansari David,Lund Lars H.,Stehlik Josef,Andersson Bodil,Höglund Peter,Edwards Leah,Nilsson Johan

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference27 articles.

1. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants;Mueller;Ann Thorac Surg,2004

2. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients;Costanzo;J Heart Lung Transplant,2010

3. Immunotherapy in transplantation;Kaplan,2012

4. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation;Flaman;J Heart Lung Transplant,2006

5. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy;Mattei;J Heart Lung Transplant,2007

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of immunosuppression induction with basiliximab compared to antithymocyte‐globulin in adult heart transplant patients;Clinical Transplantation;2024-05-28

2. A heart transplant center experience with basiliximab induction strategies: A double edged sword?;Clinical Transplantation;2024-04

3. Effect of basiliximab use on the risk of postoperative infection and death after heart transplantation: An observational study;Medicine;2023-12-08

4. Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report;Transplant Immunology;2023-12

5. Induction Therapy: When and How;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3